Internal Medicine, Medical Oncology · Orland Park, IL
NPI
1851325088
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
15300 West Ave Ste 108
Orland Park, IL, 60462
Phone (708) 226-2318
Groups this clinician bills Medicare through
Medicare paid, 2024
$500K
16,007 services
Medicare patients, 2024
235
Average age 74
Drug cost, 2024
$2.4M
949 prescriptions
Company payments, 2025
$50K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy Kuzel was code 36415 (venipuncture blood collection), 473 times for 146 patients. In total Timothy Kuzel billed 16,007 services in 87 codes, and Medicare paid $500K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 473 | 146 | $8.61 | $4,070 |
| 99215 Office E&M - Established | Office | 328 | 124 | $142.01 | $47K |
| 99214 Office E&M - Established | Office | 205 | 103 | $99.86 | $20K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 190 | 15 | $0.09 | $17.03 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 130 | 12 | $0.60 | $77.69 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 18 | $97.65 | $4,785 |
| 96375 Injection Administration | Office | 46 | 18 | $12.50 | $575 |
| 96413 Chemotherapy Administration | Office | 45 | 32 | $105.29 | $4,738 |
| 99232 Hospital E&M - Subsequent | Facility | 43 | 22 | $64.82 | $2,787 |
| 99205 Office E&M - New | Office | 40 | 40 | $168.96 | $6,759 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 25 | 23 | $13.47 | $337 |
| 99223 Hospital E&M - Initial | Facility | 24 | 20 | $142.32 | $3,416 |
| 96417 Chemotherapy Administration | Office | 16 | 13 | $51.94 | $831 |
By year: 2022 $90K for 802 services; 2023 $63K for 659 services; 2024 $500K for 16,007 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 473 | 146 | $8.61 | $4,070 |
Medicare prescription drug claims, 2024
In 2024, the drug Timothy Kuzel prescribed most often to Medicare patients was Prednisone, with 190 prescriptions and refills. In total Timothy Kuzel wrote 949 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 190 | 226 | 44 | $823 |
| Levothyroxine Sodium Generic | 62 | 124 | 17 | $713 |
| Abiraterone Acetate Generic | 60 | 64 | 13 | $92K |
| Prochlorperazine Maleate Generic | 43 | 43 | 27 | $362 |
| Ondansetron Hcl Generic | 35 | 39 | 13 | $393 |
| Eliquis Apixaban | 29 | 29 | Under 11 | $17K |
| Mirtazapine Generic | 25 | 35 | 13 | $221 |
| Cabometyx Cabozantinib S-Malate | 19 | 19 | Under 11 | $471K |
| Tamsulosin Hcl Generic | 19 | 49 | Under 11 | $415 |
| Braftovi Encorafenib | 18 | 18 | Under 11 | $304K |
| Gabapentin Generic | 18 | 26 | Under 11 | $245 |
| Dexamethasone Generic | 18 | 19 | Under 11 | $186 |
| Welireg Belzutifan | 16 | 16 | Under 11 | $345K |
| Furosemide Generic | 16 | 24 | Under 11 | $62.05 |
| Mektovi Binimetinib | 16 | 16 | Under 11 | $235K |
Brand drugs: 232 claims; generic drugs: 717 claims; opioid claims: 56.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy Kuzel $50K ($50K in general payments such as food, travel and fees) from 7 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $21K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.